其他
三阴性乳腺癌免疫治疗研究进展
▼ 图1.三阴性乳腺癌的免疫治疗及联合药物
1.Keenan TE, Tolaney SM.Role of Immunotherapy in Triple-Negative Breast Cancer. J Natl Compr Canc Netw.2020 Apr;18(4):479-489.
2.Cortes J, et al.Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previouslyuntreated locally recurrent inoperable or metastatic triple-negative breastcancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3clinical trial. Lancet. 2020 Dec 5;396(10265):1817-1828.
精彩推荐:
- End -